BetterLife Pharma (STU:NPAU) COGS-to-Revenue : 0.00 (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma COGS-to-Revenue?

BetterLife Pharma's Cost of Goods Sold for the three months ended in Jan. 2024 was €0.00 Mil. Its Revenue for the three months ended in Jan. 2024 was €0.00 Mil.

BetterLife Pharma's COGS to Revenue for the three months ended in Jan. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BetterLife Pharma's Gross Margin % for the three months ended in Jan. 2024 was N/A%.

BetterLife Pharma COGS-to-Revenue Historical Data

The historical data trend for BetterLife Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma COGS-to-Revenue Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

COGS-to-Revenue

Get a 7-Day Free Trial

BetterLife Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

BetterLife Pharma COGS-to-Revenue Calculation

BetterLife Pharma's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

BetterLife Pharma's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

BetterLife Pharma (STU:NPAU) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BetterLife Pharma's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BetterLife Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma (STU:NPAU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BETRF:USA NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines